Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12352252 | 0.89 | GAA (0.50) | GAAKDM4EKMT2AMAOBMAPK8 | |
| SCHEMBL4889822 | 0.86 | GAA (0.46) | GAAKDM4EKMT2AMAOBMTNR1A | |
| SCHEMBL8771887 | 0.85 | MAOB (0.37) | GAAKDM4EKMT2AMAOBMTNR1A | |
| SCHEMBL2594876 | 0.85 | MAOB (0.49) | GAAKDM4EKMT2AMAOBMTNR1A | |
| SCHEMBL26415573 | 0.84 | GAA (0.47) | GAAKDM4EKMT2AMAOBMAPK8 | |
| SCHEMBL1933229 | 0.84 | GAA (0.47) | GAAKDM4EKMT2AMAOBMAPK8 | |
| SCHEMBL2302254 | 0.84 | GAA (0.50) | GAAKDM4EKMT2AMAOBMTNR1A | |
| SCHEMBL316348 | 0.84 | SMN1; SMN2 (0.48) | GAAKDM4EKMT2AMAOBMAPK8 | |
| SCHEMBL1463814 | 0.84 | GAA (0.47) | GAAKDM4EKMT2AMAOBMAPK8 | |
| SCHEMBL12568166 | 0.84 | GAA (0.47) | GAAKDM4EKMT2AMAOBMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127371-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-04-27 | — | — | US | disclosed |
| WO-2021178690-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2021-09-10 | — | — | WO | disclosed |
| EP-3310819-B1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| WO-2017031239-A1 | NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-02-23 | — | — | WO | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
| US-20080064899-A1 | Method For Producing Alpha, Beta-Unsaturated Carboxylic Acid | KAWATO SEIICHI | 2008-03-13 | — | — | US | disclosed |
| US-6710204-B2 | N-OXYL COMPOUND CONTAINED IN AN EASILY POLYMERIZABLE MATERIAL CAN BE SUFFICIENTLY DECREASED AND LOSS OF EASILY POLYMERIZABLE MATERIAL (ACRYLIC OR METHACRYLIC ACIDS OR THEIR ESTERS) IS LITTLE | MITSUBISHI RAYON CO., LTD. (JP) | 2004-03-23 | — | — | US | disclosed |
| US-20030078425-A1 | Decreasing method of N-oxyl compound | MITSUBISHI RAYON CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885KDM4E 2885/4885KMT2A 1484/4885 |
| US-20030078425-A1 | Decreasing method of N-oxyl compound | NOC2L, LOXL2, VCL | GAA 722/4885KDM4E 2084/4885KMT2A 1897/4885 |
| US-20230127371-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | TNNI3, TNNT2, REN | GAA 2828/4885KDM4E 3219/4885KMT2A 4355/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885KDM4E 2885/4885KMT2A 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.